SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000947871-22-000198
Filing Date
2022-02-11
Accepted
2022-02-11 16:21:08
Documents
2
Group Members
ORBIMED CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 8 ss792112_sc13ga.htm SC 13G/A 54271
2 JOINT FILING AGREEMENT ss792112_ex99a.htm EX-99.A 8691
  Complete submission text file 0000947871-22-000198.txt   64499
Mailing Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022
Business Address 601 LEXINGTON AVENUE 54TH FLOOR NEW YORK NY 10022 (212) 739-6400
ORBIMED ADVISORS LLC (Filed by) CIK: 0001055951 (see all company filings)

IRS No.: 133976876 | State of Incorp.: DE
Type: SC 13G/A

Mailing Address 2 TOWER PLACE SUITE 2000 SOUTH SAN FRANCISCO CA 94080
Business Address 2 TOWER PLACE SUITE 2000 SOUTH SAN FRANCISCO CA 94080 6502666000
FLUIDIGM CORP (Subject) CIK: 0001162194 (see all company filings)

IRS No.: 770513190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86635 | Film No.: 22621347
SIC: 3826 Laboratory Analytical Instruments